Yili Chuanning Biotechnology Co.,Ltd. (SHE:301301)
China flag China · Delayed Price · Currency is CNY
10.92
-0.41 (-3.62%)
Feb 13, 2026, 4:00 PM EST

SHE:301301 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
747.731,088760.941,632510.05510.2
Trading Asset Securities
---1.151.210.42
Cash & Short-Term Investments
747.731,088760.941,633511.26510.62
Cash Growth
19.68%43.03%-53.41%219.44%0.13%192.94%
Accounts Receivable
1,5361,5721,4031,4171,1781,220
Other Receivables
0.860.530.632.591.191.73
Receivables
1,5371,5731,4041,4201,1791,222
Inventory
1,0721,3421,6761,3841,4531,449
Other Current Assets
665.62141.02114.9491.2572.12134.88
Total Current Assets
4,0224,1443,9564,5283,2163,316
Property, Plant & Equipment
5,8056,0465,8705,5395,9206,293
Long-Term Investments
201.770.696.786.93--
Goodwill
1.371.371.371.371.371.37
Other Intangible Assets
233.98235.83257.99283.07271.83211.54
Long-Term Deferred Tax Assets
23.6620.921.6511.346.964.02
Long-Term Deferred Charges
1.881.542.423.44.7239.93
Other Long-Term Assets
41.133.2521.6417.9740.9454.46
Total Assets
10,33110,55410,13910,3909,4629,920
Accounts Payable
655.31383.33479.98282.99427.66420.63
Accrued Expenses
28.8564.3231.5766.3220.723.09
Short-Term Debt
360.14210.15850.68978.83700.35790.75
Current Portion of Long-Term Debt
402.49608.16538.36847.26878.17628.27
Current Portion of Leases
-8.93.81.881.02-
Current Income Taxes Payable
92.6366.3736.5224.790.140.17
Current Unearned Revenue
18.6366.8228.943821.2615.78
Other Current Liabilities
243.02539.49565.85467.33513.58521.87
Total Current Liabilities
1,8011,9482,5362,7072,5632,401
Long-Term Debt
-146357.331,4282,0922,846
Long-Term Leases
464.45451.12188.1210.23.13-
Long-Term Unearned Revenue
110.9292.5183.7434.2426.227.92
Long-Term Deferred Tax Liabilities
0.01-0.310.08--
Other Long-Term Liabilities
2.82-0.08---
Total Liabilities
2,3792,6373,1654,1804,6845,254
Common Stock
2,2302,2272,2232,2232,0002,000
Additional Paid-In Capital
3,3003,2843,2523,2292,4312,431
Retained Earnings
2,3962,3861,486752.21340.7229.35
Comprehensive Income & Other
-0.1-0.1----
Total Common Equity
7,9267,8986,9606,2044,7714,660
Minority Interest
25.5418.8312.87666
Shareholders' Equity
7,9527,9166,9736,2104,7774,666
Total Liabilities & Equity
10,33110,55410,13910,3909,4629,920
Total Debt
1,2271,4241,9383,2663,6754,265
Net Cash (Debt)
-479.34-336-1,177-1,633-3,163-3,754
Net Cash Per Share
-0.21-0.15-0.53-0.83-1.70-1.88
Filing Date Shares Outstanding
2,2302,2272,2232,2232,0002,000
Total Common Shares Outstanding
2,2302,2272,2232,2232,0002,000
Working Capital
2,2212,1971,4211,820653.24915.35
Book Value Per Share
3.553.553.132.792.392.33
Tangible Book Value
7,6917,6606,7015,9204,4984,447
Tangible Book Value Per Share
3.453.443.012.662.252.22
Buildings
-3,0602,7792,6372,5602,461
Machinery
-6,2265,8615,8155,7255,449
Construction In Progress
-285.31537.860.1296.38356.08
Source: S&P Global Market Intelligence. Standard template. Financial Sources.